Title: SENATE BILL NO. 518 By: Alvord of the Senate
Official Title: SENATE BILL NO. 518 By: Alvord of the Senate
Number of Sections: 1
Source: versions - Policy Committee Recommendation
Media Type: application/pdf
Strikethrough Detection: 4 sections found

================================================================================

Section 1:
1 STATE OF OKLAHOMA
2 1st Session of the 60th Legislature (2025)
3 POLICY COMMITTEE
RECOMMENDATION
4 FOR ENGROSSED
5
and
6
West (Kevin) of the House
7
8
9
10 POLICY COMMITTEE RECOMMENDATION
11 An Act relating to medical marijuana packaging;
amending 63 O.S. 2021, Section 427.18, as last
12 amended by Section 144, Chapter 452, O.S.L. 2024 (63
O.S. Supp. 2024, Section 427.18), which relates to
13 packaging and labeling requirements; requiring
certain warnings on labels; and providing an
14 effective date.
15
16
17 BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
18 SECTION 1. AMENDATORY 63 O.S. 2021, Section 427.18, as
19 last amended by Section 144, Chapter 452, O.S.L. 2024 (63 O.S. Supp.
20 2024, Section 427.18), is amended to read as follows:
21 Section 427.18. A. A medical marijuana business shall not
22 sell, transfer or otherwise distribute medical marijuana or medical
23 marijuana product that has not been packaged and labeled in
24
Req. No. 13472 Page 1
1 acco rdance with this section and rules promulgated by the Executive
2 Director of the Oklahoma Medical Marijuana Authority.
3 B. A medical marijuana dispensary shall return medical
4 marijuana and medical marijuana product that does not meet packaging
5 or labeling requirements in this section or rules promulgated
6 pursuant thereto to the entity who transferred it to the dispensary.
7 The medical marijuana dispensary shall document to whom the item was
8 returned, what was returned, and the date of the return, or dispose
9 of any usable marijuana that does not meet these requirements in
10 accordance with the Oklahoma Medical Marijuana and Patient
11 Protection Act.
12 C. 1. Medical marijuana packaging shall be packaged to
13 minimize its appeal to children and shall not depict images other
14 than the business name logo of the medical marijuana producer and
15 image of the product.
16 2. A medical marijuana business shall not place any content on
17 a container in a manner that reasonably appears to target
18 individuals under the age of twenty-one (21) including, but not
19 limited to, cartoon characters or similar images.
20 3. Labels on a container shall not include any false or
21 misleading statements.
22 4. No container shall be intentionally or knowingly labeled so
23 as to cause a reasonable patient confusion as to whether the medical
24 marijuana, medical marijuana concentrate or medical marijuana
Req. No. 13472 Page 2
1 prod uct is a trademarked product or labeled in a manner that
2 violates any federal trademark law or regulation. The label on the
3 container shall include a warning that states the following:
4 a. “For use by licensed medical marijuana patients only”,
5 and
6 b. “Keep out of reach of children”,
7 c. “It is illegal to drive a motor vehicle while under
8 the influence of marijuana or marijuana products”,
9 d. "Women should not use marijuana or marijuana products
10 during pregnancy because of the risk of birth
11 defects", and
12 e. "This product has been tested for contaminants".
13 5. The label on the container shall not make any claims
14 regarding health or physical benefits to the patient.
15 6. The container itself may be clear in order to allow licensed
16 medical marijuana patients and licensed medical marijuana caregivers
17 the ability to view the product inside the container but shall be
18 child-resistant, as defined in Section 427.2 of this title.
19 7. At the point of sale and transfer of any medical marijuana,
20 medical marijuana concentrate, or medical marijuana products to a
21 licensed medical marijuana patient or licensed medical marijuana
22 caregiver, the dispensary shall place the medical marijuana, medical
23 marijuana concentrate, or medical marijuana products in an exit
24 package, as such term is defined in Section 427.2 of this title.
Req. No. 13472 Page 3
1 D. The Executive Director shall develop minimum standards for
2 packaging and labeling of medical marijuana, medical marijuana
3 concentrate, and medical marijuana products. Such standards shall
4 include, but not be limited to, the required contents of labels to
5 be affixed to all medical marijuana, medical marijuana concentrate,
6 and medical marijuana products prior to transfer to a licensed
7 patient or caregiver, which shall include, at a minimum:
8 1. THC and other cannabinoid potency, and terpenoid potency;
9 2. A statement indicating that the product has been tested for
10 contaminants;
11 3. One or more product warnings to be determined by the
12 Executive Director; and
13 4. Any other information the Executive Director deems
14 necessary.
15 SECTION 2. This act shall become effective November 1, 2025.
16
17 60-1-13472 JL 04/09/25
18
19
20
21
22
23
24
Req. No. 13472 Page 4
[DELETED:  PS B A  a W]
[DELETED:  P]
[DELETED:  P “ “ “ " "]
[DELETED:  P J 0]


================================================================================

Raw Text:
1 STATE OF OKLAHOMA
2 1st Session of the 60th Legislature (2025)
3 POLICY COMMITTEE
RECOMMENDATION
4 FOR ENGROSSED
SENATE BILL NO. 518 By: Alvord of the Senate
5
and
6
West (Kevin) of the House
7
8
9
10 POLICY COMMITTEE RECOMMENDATION
11 An Act relating to medical marijuana packaging;
amending 63 O.S. 2021, Section 427.18, as last
12 amended by Section 144, Chapter 452, O.S.L. 2024 (63
O.S. Supp. 2024, Section 427.18), which relates to
13 packaging and labeling requirements; requiring
certain warnings on labels; and providing an
14 effective date.
15
16
17 BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
18 SECTION 1. AMENDATORY 63 O.S. 2021, Section 427.18, as
19 last amended by Section 144, Chapter 452, O.S.L. 2024 (63 O.S. Supp.
20 2024, Section 427.18), is amended to read as follows:
21 Section 427.18. A. A medical marijuana business shall not
22 sell, transfer or otherwise distribute medical marijuana or medical
23 marijuana product that has not been packaged and labeled in
24
Req. No. 13472 Page 1

1 acco rdance with this section and rules promulgated by the Executive
2 Director of the Oklahoma Medical Marijuana Authority.
3 B. A medical marijuana dispensary shall return medical
4 marijuana and medical marijuana product that does not meet packaging
5 or labeling requirements in this section or rules promulgated
6 pursuant thereto to the entity who transferred it to the dispensary.
7 The medical marijuana dispensary shall document to whom the item was
8 returned, what was returned, and the date of the return, or dispose
9 of any usable marijuana that does not meet these requirements in
10 accordance with the Oklahoma Medical Marijuana and Patient
11 Protection Act.
12 C. 1. Medical marijuana packaging shall be packaged to
13 minimize its appeal to children and shall not depict images other
14 than the business name logo of the medical marijuana producer and
15 image of the product.
16 2. A medical marijuana business shall not place any content on
17 a container in a manner that reasonably appears to target
18 individuals under the age of twenty-one (21) including, but not
19 limited to, cartoon characters or similar images.
20 3. Labels on a container shall not include any false or
21 misleading statements.
22 4. No container shall be intentionally or knowingly labeled so
23 as to cause a reasonable patient confusion as to whether the medical
24 marijuana, medical marijuana concentrate or medical marijuana
Req. No. 13472 Page 2

1 prod uct is a trademarked product or labeled in a manner that
2 violates any federal trademark law or regulation. The label on the
3 container shall include a warning that states the following:
4 a. “For use by licensed medical marijuana patients only”,
5 and
6 b. “Keep out of reach of children”,
7 c. “It is illegal to drive a motor vehicle while under
8 the influence of marijuana or marijuana products”,
9 d. "Women should not use marijuana or marijuana products
10 during pregnancy because of the risk of birth
11 defects", and
12 e. "This product has been tested for contaminants".
13 5. The label on the container shall not make any claims
14 regarding health or physical benefits to the patient.
15 6. The container itself may be clear in order to allow licensed
16 medical marijuana patients and licensed medical marijuana caregivers
17 the ability to view the product inside the container but shall be
18 child-resistant, as defined in Section 427.2 of this title.
19 7. At the point of sale and transfer of any medical marijuana,
20 medical marijuana concentrate, or medical marijuana products to a
21 licensed medical marijuana patient or licensed medical marijuana
22 caregiver, the dispensary shall place the medical marijuana, medical
23 marijuana concentrate, or medical marijuana products in an exit
24 package, as such term is defined in Section 427.2 of this title.
Req. No. 13472 Page 3

1 D. The Executive Director shall develop minimum standards for
2 packaging and labeling of medical marijuana, medical marijuana
3 concentrate, and medical marijuana products. Such standards shall
4 include, but not be limited to, the required contents of labels to
5 be affixed to all medical marijuana, medical marijuana concentrate,
6 and medical marijuana products prior to transfer to a licensed
7 patient or caregiver, which shall include, at a minimum:
8 1. THC and other cannabinoid potency, and terpenoid potency;
9 2. A statement indicating that the product has been tested for
10 contaminants;
11 3. One or more product warnings to be determined by the
12 Executive Director; and
13 4. Any other information the Executive Director deems
14 necessary.
15 SECTION 2. This act shall become effective November 1, 2025.
16
17 60-1-13472 JL 04/09/25
18
19
20
21
22
23
24
Req. No. 13472 Page 4

[DELETED:  PS B A  a W]
[DELETED:  P]
[DELETED:  P “ “ “ " "]
[DELETED:  P J 0]